Fungus fuels mucosal wounds in Crohn's disease

Kevin M Magnaye1, Susan V Lynch1

  • 1Department of Medicine, University of California, San Francisco, CA, USA.

Immunity
|May 12, 2021
PubMed

Insights

The yeast Debaryomyces hansenii hinders gut healing in mice by affecting immune responses. This fungus is also found in inflamed tissues of Crohn's disease patients, suggesting a role in the condition.

Area of Science:

  • Microbiology
  • Immunology
  • Gastroenterology

Background:

  • Crohn's disease (CD) is linked to gut microbiome changes, but specific causative agents are unknown.
  • Understanding factors contributing to CD pathophysiology is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role of Debaryomyces hansenii in intestinal healing.
  • To explore the mechanisms by which D. hansenii affects the host immune system in the context of gut inflammation.

Main Methods:

  • Experiments were conducted in mouse models of intestinal healing.
  • Analysis involved assessing the impact of D. hansenii on immune signaling pathways, specifically type I interferon and chemokine CCL5.
  • Microbial and tissue samples from Crohn's disease patients were analyzed for the presence of D. hansenii.

Main Results:

  • Debaryomyces hansenii was found to impair intestinal healing in mice.
  • This impairment was associated with alterations in type I interferon signaling and CCL5 chemokine expression in macrophages.
  • D. hansenii was identified as prevalent in the inflamed mucosa of patients with Crohn's disease.

Conclusions:

  • Debaryomyces hansenii may contribute to the pathophysiology of Crohn's disease by hindering intestinal repair.
  • The fungus's effects on macrophage immune signaling highlight a potential mechanism for its detrimental impact on gut health.

Related Concept Videos

Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
463
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
520
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
905
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
761
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
277
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
216